摘要
本文探究苯达莫司汀联合伊沙佐米治疗多发性骨髓瘤(MM)患者sVCAM-1、β2-MG的超声评估价值。选取100例多发性骨髓瘤患者为研究对象,随机分为对照组(50例)和研究组(50例)。两组均进行对症治疗,对照组给予地塞米松+苯达莫司汀,研究组给予地塞米松+苯达莫司汀+伊沙佐米。在治疗前后,两组患者均行超声检查,并检测患者sVCAM-1、β2-MG水平。治疗后,两组患者sVCAM-1、β2-MG、皮质IBS、髓质IBS、叶间动脉RI水平下降,且研究组低于对照组,肾脏体积、肾脏长度、叶间动脉PSV水平均升高,且研究组明显高于对照组(P<0.05)。与研究组治疗无效患者相比,治疗有效患者肾脏体积、肾脏长度、叶间动脉PSV水平较高,皮质IBS、髓质IBS、叶间动脉RI水平较低(P<0.05)。研究组治疗有效率明显高于对照组(P<0.05)。综上可知,多发性骨髓瘤患者经苯达莫司汀联合伊沙佐米治疗后sVCAM-1、β2-MG水平下降,临床疗效理想,同时,经联合治疗后超声参数明显变化,提示超声可用于多发性骨髓瘤患者临床疗效的评估。
This paper exploreed the value of bendamustine combined with ixazomib for sVCAM-1 and β2-MG in patients with multiple myeloma(MM). Selected 100 multiple myeloma patients as research subjects, and divided them into the control group with 50 patients and 50 patients in the study group randomly. Both the two groups were given symptomatic treatment, the control group received dexamethasone plus bendamustine, and the study group gave dexamethasone plus bendamustine plus ixazomib. Before and after treatment, the patients in both groups were examined by ultrasound, the sVCAM-1 and β2-MG levels were tested as well. After treatment, the sVCAM-1, β2-MG, cortical IBS, medulla IBS, interlobe artery RI levels decreased, and the study group was lower than the control group. The kidney volume, kidney length, interlobe artery PSV levels increased, and the study group was higher than the control group(P<0.05). Compared with the ineffective patients in the study group, the effective patients had higher levels of kidney volume, kidney length, and interlobar artery PSV, while lower cortical IBS, medulla IBS, and interlobar artery RI levels(P<0.05). The effective rate of treatment in the study group was significantly higher than that in the control group(P<0.05).To sum up,the levels of sVCAM-1andβ2-MG in patients with multiple myeloma decreased after bendamustine combined with ixazomib treatment,and the clinical efficacy was satisfactory,and the ultrasound parameters changed significantly after the combined treatment,which suggested that ultrasound can be used for evaluation of clinical efficacy in patients with multiple myeloma.
作者
刘敏
余卓君
梁艳
黄知平
唐元艳
LIU Min;YU Zhuojun;LIANG Yan;HUANG Zhiping;TANG Yuanyan(Department of Hematology,Jingzhou Hospital Affiliated to Yangtze University,Jingzhou 434020,Hubei,P.R.China)
出处
《影像科学与光化学》
CAS
北大核心
2022年第5期1174-1178,共5页
Imaging Science and Photochemistry
